Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. FCF to Net Income
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF to Net Income | 36.9% | (19.8%) | (8.5%) | 149.9% | 250.0% | 3.2% | 89.7% | (16.5%) | 101.9% | 120.5% | 102.6% | 108.8% | 86.3% | 74.1% | 94.5% | 57.0% | 80.9% | 102.0% | 92.8% | 83.0% |
Regeneron Pharmaceuticals, Inc. (REGN) FCF to Net Income comparison analysis
REGN key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
FAQ
1) What is Regeneron Pharmaceuticals, Inc.'s FCF to Net Income?
As of today, Microsoft Corp's last 12-month FCF to Net Income is 81.5%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual FCF to Net Income for Regeneron Pharmaceuticals, Inc. have been 89.8% over the past three years, and 87.8% over the past five years.
2) Is Regeneron Pharmaceuticals, Inc.'s FCF to Net Income Good?
As of today, Regeneron Pharmaceuticals, Inc.'s FCF to Net Income is 81.5%, which is lower than industry median of 84.2%. It indicates that Regeneron Pharmaceuticals, Inc.'s FCF to Net Income is Bad.